|
Re: Comments re AHA presentation
|
3
|
Resverlogix Corp.
|
Nov 16, 2019 10:38PM
|
|
Re: Comments re AHA presentation
|
3
|
Resverlogix Corp.
|
Nov 16, 2019 11:04PM
|
|
Re: Comments re AHA presentation
|
4
|
Resverlogix Corp.
|
Nov 16, 2019 11:17PM
|
|
Re: Breakthrough Therapy Question
|
5
|
Resverlogix Corp.
|
Jan 06, 2020 03:00PM
|
|
Re: Breakthrough Therapy Question
|
3
|
Resverlogix Corp.
|
Jan 06, 2020 04:00PM
|
|
Re: BRD2 involvement in Covid19
|
4
|
Resverlogix Corp.
|
Mar 18, 2020 12:14PM
|
|
Re: BRD2 involvement in Covid19
|
6
|
Resverlogix Corp.
|
Mar 18, 2020 12:28PM
|
|
Re: BRD2 involvement in Covid19
|
3
|
Resverlogix Corp.
|
Mar 18, 2020 12:40PM
|
|
Re: BRD2 involvement in Covid19
|
2
|
Resverlogix Corp.
|
Mar 18, 2020 01:03PM
|
|
Re: BRD2 involvement in Covid19
|
3
|
Resverlogix Corp.
|
Mar 18, 2020 01:10PM
|
|
Re: BOM 2 Trial
|
5
|
Resverlogix Corp.
|
Jun 10, 2020 12:12PM
|
|
Re: BIO CEO Slides Up
|
2
|
Resverlogix Corp.
|
Sep 18, 2019 07:00PM
|
|
Re: BETonMACE summary from Webcast 11/18/19
|
2
|
Resverlogix Corp.
|
Nov 18, 2019 01:46PM
|
|
Re: BD2 specific inhibitors mentioned in Science
|
4
|
Resverlogix Corp.
|
Mar 22, 2020 01:46PM
|
|
Re: balancing success and failure
|
4
|
Resverlogix Corp.
|
Nov 19, 2019 08:59PM
|
|
Re: balancing success and failure
|
6
|
Resverlogix Corp.
|
Nov 19, 2019 10:37PM
|
|
Re: balancing success and failure
|
3
|
Resverlogix Corp.
|
Nov 20, 2019 12:13AM
|
|
Re: balancing success and failure
|
3
|
Resverlogix Corp.
|
Nov 20, 2019 12:34AM
|
|
Re: balancing success and failure
|
6
|
Resverlogix Corp.
|
Nov 20, 2019 12:38PM
|
|
Re: balancing success and failure
|
5
|
Resverlogix Corp.
|
Nov 20, 2019 01:59PM
|
